Regina E Groves insider trades

Open-market stock purchases and sales by Regina E Groves, Director at AtriCure, Inc, from SEC Form 4 filings since Sep 24, 2015.

Track record: 67% of 3 scored buys are up 5% or more since purchase, averaging +113%.

Recent trades

DateStockTradeValue
Sep 11, 2026ATRC AtriCure, IncSold$288K
May 18, 2026ATRC AtriCure, IncBought (not open market)—
May 14, 2026FLGT Fulgent Genetics, IncBought (not open market)—

Companies traded

  • ATRC AtriCure, Inc: 3 buys, 5 sales, last Sep 11, 2026
  • FLGT Fulgent Genetics, Inc: other filings, last May 14, 2026
  • RVA.AX REVA Medical, Inc: 1 buy, last Jun 29, 2018
  • RVA:AX REVA Medical, Inc: 6 buys, last Aug 29, 2017

Get free alerts when Regina E Groves files a new trade →